Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DLN.L Stock Summary
Top 10 Correlated ETFs
DLN.L
In the News
DLN.L Financial details
Company Rating
Sell
Market Cap
2.33B
Income
-756.9M
Revenue
516.8M
Book val./share
31.25
Cash/share
0.65
Dividend
0.79
Dividend %
0.03%
Employees
199
Optionable
No
Shortable
Yes
Earnings
28 Feb 2024
P/E
-18.47
Forward P/E
-
PEG
-1.09
P/S
20.81
P/B
0.67
P/C
3126.15
P/FCF
-12.87
Quick Ratio
0.21
Current Ratio
1.09
Debt / Equity
0.38
LT Debt / Equity
0.35
-
-
EPS (TTM)
-6.74
EPS next Y
-
EPS next Q
-
EPS this Y
69.6%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.31%
Revenue Q/Q
-0.74%
EPS Q/Q
132.03%
-
-
-
-
SMA20
-2.8%
SMA50
-0.97%
SMA100
-5.37%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-5%
ROC
0.02%
Gross Margin
78%
Oper. Margin
63%
Profit Margin
-113%
Payout
-31%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1766.0-2478.0
52W High
-18%
52W Low
+15.06%
RSI
47
Rel Volume
0.54
Avg Volume
277.55K
Volume
151.01K
Perf Week
-1.17%
Perf Month
0.4%
Perf Quarter
12.7%
Perf Half Y
7.86%
-
-
-
-
Beta
0.941
-
-
Volatility
32.75%, 48.44%
Prev Close
-0.59%
Price
2032
Change
3.04%
DLN.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.04 | 2.38 | 2.14 | 2.22 | 2.38 | |
Net income per share | 2.54 | -0.69 | 2.25 | -2.5 | -4.24 | |
Operating cash flow per share | 1.14 | 0.77 | 1.15 | 0.99 | 0.86 | |
Free cash flow per share | 1.14 | 0.76 | 1.14 | 0.97 | 0.86 | |
Cash per share | 0.49 | 0.45 | 0.94 | 0.68 | 0.65 | |
Book value per share | 39.6 | 38.09 | 39.61 | 36.3 | 31.25 | |
Tangible book value per share | 40.1 | 38.56 | 39.61 | 36.3 | 31.25 | |
Share holders equity per share | 39.6 | 38.09 | 39.61 | 36.3 | 31.25 | |
Interest debt per share | 10.13 | 10.53 | 11.96 | 11.55 | 12.23 | |
Market cap | 4.48B | 3.46B | 3.83B | 2.66B | 2.65B | |
Enterprise value | 5.46B | 4.51B | 5.04B | 3.87B | 3.95B | |
P/E ratio | 15.8 | -44.65 | 15.18 | -9.48 | -5.56 | |
Price to sales ratio | 19.67 | 12.98 | 15.94 | 10.68 | 9.9 | |
POCF ratio | 35.14 | 40.38 | 29.71 | 23.86 | 27.32 | |
PFCF ratio | 35.23 | 40.57 | 30.08 | 24.3 | 27.52 | |
P/B Ratio | 1.01 | 0.81 | 0.86 | 0.65 | 0.76 | |
PTB ratio | 1.01 | 0.81 | 0.86 | 0.65 | 0.76 | |
EV to sales | 23.98 | 16.91 | 20.99 | 15.53 | 14.74 | |
Enterprise value over EBITDA | 38.04 | 30.83 | 32.77 | 23.47 | 25.94 | |
EV to operating cash flow | 42.85 | 52.61 | 39.13 | 34.7 | 40.7 | |
EV to free cash flow | 42.95 | 52.86 | 39.62 | 35.34 | 40.99 | |
Earnings yield | 0.06 | -0.02 | 0.07 | -0.11 | -0.18 | |
Free cash flow yield | 0.03 | 0.02 | 0.03 | 0.04 | 0.04 | |
Debt to equity | 0.24 | 0.27 | 0.29 | 0.31 | 0.38 | |
Debt to assets | 0.19 | 0.21 | 0.22 | 0.23 | 0.27 | |
Net debt to EBITDA | 6.84 | 7.17 | 7.89 | 7.33 | 8.53 | |
Current ratio | 2.4 | 2.83 | 1.34 | 1.27 | 0.74 | |
Interest coverage | 3.01 | 3.62 | 3.82 | 3.51 | 4.11 | |
Income quality | 0.45 | -1.11 | 0.51 | -0.4 | -0.2 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Payout ratio | 0.26 | -1.05 | 0.33 | -0.31 | -0.19 | |
Sales general and administrative to revenue | 0.16 | 0.14 | 0.15 | 0.15 | 0.15 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0.86 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | -0.01 | -0.02 | -0.01 | |
Capex to revenue | 0 | 0 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -0.43 | -0.57 | -1.78 | -2 | -0.64 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Graham number | 47.55 | 24.38 | 44.78 | 45.17 | 54.61 | |
ROIC | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
Return on tangible assets | 0.05 | -0.01 | 0.3 | -0.05 | -0.09 | |
Graham Net | -9.6 | -10.15 | -11.93 | -11.83 | -12.49 | |
Working capital | 158.7M | 197M | 71.3M | 45.7M | -66.4M | |
Tangible asset value | 4.48B | 4.32B | -624.8M | 4.08B | 3.51B | |
Net current asset value | -883.8M | -911.5M | -1.19B | -1.22B | -1.33B | |
Invested capital | 0.24 | 0.27 | 0.29 | 0.31 | 0.38 | |
Average receivables | 11.5M | 21.95M | 21.1M | 10.65M | 11.55M | |
Average payables | 4.3M | 4.85M | 2.85M | 1.8M | 16.6M | |
Average inventory | 38.5M | 26.8M | 22.75M | 37.15M | 55.3M | |
Days sales outstanding | 19.73 | 43.21 | 16.1 | 15.68 | 16.9 | |
Days payables outstanding | 54.3 | 12.98 | 22.33 | 2.58 | 162.66 | |
Days of inventory on hand | 306.93 | 66.98 | 227.51 | 269.39 | 341.69 | |
Receivables turnover | 18.5 | 8.45 | 22.67 | 23.27 | 21.6 | |
Payables turnover | 6.72 | 28.12 | 16.34 | 141.25 | 2.24 | |
Inventory turnover | 1.19 | 5.45 | 1.6 | 1.35 | 1.07 | |
ROE | 0.06 | -0.02 | 0.06 | -0.07 | -0.14 | |
Capex per share | 0 | 0 | -0.01 | -0.02 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.07 | 1.09 | 1.13 | 1.2 | 1.19 | |
Net income per share | 1.18 | 1.21 | -3.7 | -1.28 | -2.97 | |
Operating cash flow per share | 0.66 | 0.46 | 0.53 | 0.39 | 0.47 | |
Free cash flow per share | 0.66 | -0.15 | 1.13 | 0.39 | 0.47 | |
Cash per share | 0.61 | 0.29 | 0.68 | 0.88 | 0.65 | |
Book value per share | 39.59 | 40.28 | 36.3 | 34.46 | 31.25 | |
Tangible book value per share | 39.59 | 40.28 | 36.3 | 34.46 | 31.25 | |
Share holders equity per share | 39.59 | 40.28 | 36.3 | 34.46 | 31.25 | |
Interest debt per share | 11.77 | 12.46 | 11.34 | 11.59 | 12.11 | |
Market cap | 3.83B | 2.93B | 2.66B | 2.3B | 2.65B | |
Enterprise value | 5.08B | 4.29B | 3.87B | 3.52B | 3.95B | |
P/E ratio | 7.25 | 5.41 | -1.6 | -4.02 | -1.99 | |
Price to sales ratio | 32.01 | 24.06 | 20.9 | 17.13 | 19.87 | |
POCF ratio | 51.5 | 56.9 | 44.38 | 52.56 | 49.81 | |
PFCF ratio | 52.06 | -171.35 | 21.02 | 53.04 | 50.1 | |
P/B Ratio | 0.86 | 0.65 | 0.65 | 0.59 | 0.76 | |
PTB ratio | 0.86 | 0.65 | 0.65 | 0.59 | 0.76 | |
EV to sales | 42.47 | 35.23 | 30.39 | 26.17 | 29.59 | |
Enterprise value over EBITDA | 66.1 | 52.26 | 46.81 | 46.09 | 52.01 | |
EV to operating cash flow | 68.33 | 83.32 | 64.54 | 80.29 | 74.21 | |
EV to free cash flow | 69.07 | -250.92 | 30.56 | 81.03 | 74.63 | |
Earnings yield | 0.03 | 0.05 | -0.16 | -0.06 | -0.13 | |
Free cash flow yield | 0.02 | -0.01 | 0.05 | 0.02 | 0.02 | |
Debt to equity | 0.29 | 0.3 | 0.31 | 0.33 | 0.38 | |
Debt to assets | 0.22 | 0.23 | 0.23 | 0.24 | 0.27 | |
Net debt to EBITDA | 16.27 | 16.57 | 14.62 | 15.92 | 17.1 | |
Current ratio | 1.34 | 1.82 | 1.27 | 1.09 | 0.74 | |
Interest coverage | 3.73 | 3.49 | 3.52 | 3.3 | 3.15 | |
Income quality | 0.56 | 0.38 | -0.14 | -0.31 | -0.16 | |
Dividend Yield | 0.01 | 0.02 | 0.01 | 0.03 | 0.01 | |
Payout ratio | 0.21 | 0.43 | -0.07 | -0.41 | -0.09 | |
Sales general and administrative to revenue | 0.15 | 0.15 | 0.15 | 0.14 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.86 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.01 | -1.33 | 1.11 | -0.01 | -0.01 | |
Capex to revenue | -0.01 | -0.56 | 0.52 | 0 | 0 | |
Capex to depreciation | -1.6 | -137.2 | 133.2 | -0.8 | -0.5 | |
Stock based compensation to revenue | 0.04 | 0 | 0.01 | 0 | 0 | |
Graham number | 32.38 | 33.06 | 55 | 31.44 | 45.67 | |
ROIC | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | |
Return on tangible assets | 0.16 | 0.02 | -0.08 | -0.03 | -0.07 | |
Graham Net | -12.1 | -13.01 | -11.83 | -11.94 | -12.49 | |
Working capital | 71.3M | 117.1M | 45.7M | 16.3M | -66.4M | |
Tangible asset value | -604.1M | 4.52B | 4.08B | 3.87B | 3.51B | |
Net current asset value | -1.17B | -1.26B | -1.22B | -1.28B | -1.33B | |
Invested capital | 0.29 | 0.3 | 0.31 | 0.33 | 0.38 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 7.97 | 14.33 | 7.57 | 11.99 | 8.37 | |
Days payables outstanding | 10.07 | 24.33 | 1.22 | 23.78 | 84.34 | |
Days of inventory on hand | 102.59 | 108.33 | 127.22 | 118.21 | 177.17 | |
Receivables turnover | 11.29 | 6.28 | 11.89 | 7.51 | 10.76 | |
Payables turnover | 8.94 | 3.7 | 73.75 | 3.78 | 1.07 | |
Inventory turnover | 0.88 | 0.83 | 0.71 | 0.76 | 0.51 | |
ROE | 0.03 | 0.03 | -0.1 | -0.04 | -0.09 | |
Capex per share | -0.01 | -0.61 | 0.59 | 0 | 0 |
DLN.L Frequently Asked Questions
What is Derwent London Plc stock symbol ?
Derwent London Plc is a GB stock and trading under the symbol DLN.L
What is Derwent London Plc stock quote today ?
Derwent London Plc stock price is $2032 today.
Is Derwent London Plc stock public?
Yes, Derwent London Plc is a publicly traded company.